# Compass Therapeutics, Inc. (CMPX) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from Compass Therapeutics, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/CMPX/mda/fy2025/): filed 2026-03-05; accession 0001171843-26-001337 (https://www.sec.gov/Archives/edgar/data/1738021/000117184326001337/cmpx20251231_10k.htm); latest 10-K
- [FY 2024 MD&A](/company/CMPX/mda/fy2024/): filed 2025-02-27; accession 0001171843-25-001106 (https://www.sec.gov/Archives/edgar/data/1738021/000117184325001106/cmpx20241231_10k.htm)
- [FY 2023 MD&A](/company/CMPX/mda/fy2023/): filed 2024-03-21; accession 0001171843-24-001516 (https://www.sec.gov/Archives/edgar/data/1738021/000117184324001516/cmpx20231231_10k.htm)
- [FY 2022 MD&A](/company/CMPX/mda/fy2022/): filed 2023-03-15; accession 0001171843-23-001691 (https://www.sec.gov/Archives/edgar/data/1738021/000117184323001691/cmpx20221231_10k.htm)
- [FY 2021 MD&A](/company/CMPX/mda/fy2021/): filed 2022-03-18; accession 0000950170-22-004156 (https://www.sec.gov/Archives/edgar/data/1738021/000095017022004156/cmpx-20211231.htm)

Back to /company/CMPX/